De 2006 a 2010


237. PAIVA L., A. HERNÁNDEZ, V. MARTÍNEZ, A. CREUS, D. QUINTEROS, R. MARCOS. Association between GSTO2 polymorphism and the urinary arsenic profile in copper industry workers. Environmental Research, 110(5): 463-468 (2010).

238. STOYANOVA E., S.B. SANDOVAL, L.A. ZÚÑIGA, N. EL-YAMANI, E. COLL, S. PASTOR, J. REYES, E. ANDRÉS, J. BALLARIN, N. XAMENA, R. MARCOS. Oxidative DNA damage in chronic renal failure patients. Nephrology Dialysis Transplantation, 25(3): 879-885 (2010).

239. LIVIAC D., A. CREUS, R. MARCOS. DNA damage induction by two halogenated acetaldehydes, byproducts of water disinfection. Water Research, 44(8): 2638-2646 (2010).

240. DEMIR E., S. KOCAOĞLU, B. KAYA, R. MARCOS. Induction of adaptive response in Drosophila after exposure to low doses of UVB. International Journal of Radiation Biology, 86(11): 957-963 (2010).

241. AKDI A., E.M. GIMÉNEZ, W. GARCIA-QUISPES, S. PASTOR, J. CASTELL, J. BIARNÉS, R. MARCOS, A. VELÁZQUEZ. WDR3 gene haplotype associated with thyroid cancer risk is a Spanish population. Thyroid, 20(7): 803-809 (2010).

242. LIVIAC D., E.D. WAGNER, W.A. MITCH, M.J. ALTONJI, M.J. PLEWA. Genotoxicity of water concentrates from recreational pools after various disinfection methods. Environmental Science Technology, 44(9): 3527-3532 (2010).

243. LIVIAC D., A. CREUS, R. MARCOS. Genotoxicity testing of three monohaloacetic acids in TK6 cells using the cytokinesis-block micronucleus assay. Mutagenesis, 25 (5): 505-509 (2010).

244. SAMPAYO-REYES A., A. HERNÁNDEZ, N. EL-YAMANI, C. LÓPEZ-CAMPOS, E. MAYET-MACHADO, C.B. RINCÓN-CASTAÑEDA, M.L. LIMONES-AGUILAR, J.E. LÓPEZ-CAMPOS, M.B. DE LEÓN, S. GONZÁLEZ-HERNÁNDEZ, D. HINOJOSA-GARZA, R. MARCOS. Arsenic induces DNA damage in environmentally exposed Mexican children and adults. Influence of GSTO1 and AS3MT polymorphisms. Toxicological Sciences, 117(1): 63-71 (2010).

245. RICHARDSON S.D., D.M. DEMARINI, M. KOGEVINAS, P. FERNANDEZ, E. MARCO, C. LOURENCETTI, C. BALLESTE, D. HEEDERIK, K. MELIEFSTE, A.B. MCKAGUE, R. MARCOS, L. FONT-RIBERA, J.O. GRIMALT, C.M. VILLANUEVA. What’s in the pool?  A comprehensive identification of disinfection by-products and   assessment of mutagenicity of chlorinated and brominated swimming pool water, Environmental and Health Perspectives, 118(11): 1523-1530 (2010).

246. M. KOGEVINAS, C.M VILLANUEVA, L. FONT-RIBERA, D. LIVIAC, M. BUSTAMANTE, F. ESPINOZA, M.J. NIEUWENHUIJSEN, A. ESPINOSA, P. FERNANDEZ, D.M. DEMARINI, J.O. GRIMALT, T. GRUMMT, R. MARCOS. Genotoxic effects in swimmers exposed to disinfection by-products in indoor swimming pools. Environmental and Health Perspectives, 118(11): 1531-1537 (2010).

247. FONT-RIBERA L., M. KOGEVINAS, J.P. ZOCK, F.P. GÓMEZ, E. BARREIRO, M.J. NIEUWENHUIJSEN, P. FERNÁNDEZ, J.O. GRIMALT, R. MARCOS, C..M. VILLANUEVA. Short-term changes in respiratory biomarkers after swimming in a chlorinated pool. Environmental and Health Perspectives, 118 (11) 1538-1544 (2010).

248. SANDOVAL S.B., E. STOYANOVA, E. COLL, S. PASTOR, J. REYES, E. ANDRÉS, J. BALLARIN, N. XAMENA, R. MARCOS. Glomerular filtration rate index is associated with genetic damage in chronic renal failure patients. Mutagenesis 25(6): 603-608 (2010).



231. DECORDIER I., A. PAPINE, G. PLAS, S. ROESEMS, K. VANDE LOOCK, J. MORENO, E. CEMELI, D. ANDERSON, A. FUCIC, R. MARCOS, F. SOUSSALINE, M. KIRSCH-VOLDERS. Automated image analysis of cytokinesis-blocked micronuclei: an adapted protocol and a validated scoring procedure for biomonitoring. Mutagenesis, 24(1): 85-93 (2009).

232.   PRADO G., J.A. BHALLI, R. MARCOS. Genotoxicity of heptachlor and heptachlor epoxide in human TK6 lymphoblastoid cells. Mutation Research (GTEM), 673(2): 87-91 (2009).

233.   GÜERCI A., D. LIVIAC, R. MARCOS. Detection of excision repaired DNA damage in the comet assay by using Ara-C and hydroxyurea in three different cell types. Cell Biology and Toxicology, 25(1): 73-80 (2009).

234.   LIVIAC D., A. CREUS, R. MARCOS. Genotoxicity analysis of two halonitromethanes, a novel group of disinfection by-products (DBPs), in human cells treated in vitro Environmental Research, 109(3): 232-238 (2009).

235.   GARCÍA-QUISPES W.A., E.R. CARMONA, A. CREUS, R. MARCOS. Genotoxic evaluation of two halonitromethane disinfection by-products in the Drosophila wing spot test. Chemosphere, 75(7): 906-909 (2009).  

236.   LIVIAC D., A. CREUS, R. MARCOS. Genotoxicity analysis of two hydroxyl-furanones, byproducts of water disinfection, in human cells treated in vitro. Environmental and Molecular Mutagenesis, 50(5): 413-420 (2009).



213.   HERNÁNDEZ A., N. XAMENA, J. SURRALLÉS, C. SEKARAN, H. TOKUNAGA, D. QUINTEROS, A. CREUS, R. MARCOS. Role of the Met287Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. Mutation Research (FMMM), 637(1-2): 80-92 (2008).

214.   CARMONA E.R., E. KOSSATZ, A. CREUS, R. MARCOS. Genotoxic evaluation of two mercury compounds in the Drosophila wing spot test. Chemosphere, 70(10): 1910-1914 (2008).

215.   PAIVAL., R. MARCOS, A. CREUS, M. COGGAN, A.J. OAKLEY, P.G. BOARD. Polymorphism of glutathione transferase Omega 1 in a population exposed to a high environmental arsenic burden.  Pharmacogenetics and Genomics, 18(1): 1-10 (2008).

216.   PAIVA L., V. MARTÍNEZ, A. CREUS, D. QUINTEROS, R. MARCOS. Evaluation of micronucleus frequencies in blood lymphocytes from smelting plant workers exposed to arsenic. Environmental and Molecular Mutagenesis, 49(3): 200-205 (2008).

217. ENNANCEUR S., D. RIDHA, R. MARCOS.Genotoxicity of the organochlorine pesticides 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and hexachloro-benzene (HCB) in cultured human lymphocytes. Chemosphere, 71(7): 1335-1339 (2008).

218.   ESPINOZA F., D. SILVERMAN, M. KOGEVINAS, A. CREUS, F. FERNÁNDEZ, M. GARCÍA-CLOSAS, A. TARDÓN, R. GARCÍA-CLOSAS, C. SERRA, A. CARRATO, N. ROTHMAN, M. DOSEMECI, N. MALATS, R. MARCOS. Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms. Cancer Letters, 263(2): 259-266 (2008).

219.   HERNÁNDEZ A., N. XAMENA, C. SEKARAN, H. TOKUNAGA, A. SAMPAYO-REYES, D. QUINTEROS, A. CREUS, R. MARCOS. High arsenic metabolic efficiency in AS3MT 287Thr allele carriers. Pharmacogenetics and Genomics, 18(4): 349-355 (2008).

220.   BAIDA A., M. AKDI, E. GONZALEZ-FLORES, P. GALOFRÉ, R. MARCOS, A. VELÁZQUEZ. Strong association of chromosome 1p12 loci with thyroid cancer susceptibility. Cancer Epidemiology Biomarkers and Prevention, 17(6): 1499-1504 (2008).

221.   GUZMÁN A., C. GARCÍA, A.P. MARÍN, R.J. PROUDLOCK, A.R. FERNÁNDEZ DE HENESTROSA, M.T. RUIZ, A. TORTAJADA, M. LLOYD, R. MARCOS. Evaluation of the genotoxic potential of three phenyltetrahydropyridinyl butylazole-derived sigma-receptor ligand drug candidates. Mutation Research (GTEM), 653(1-2): 91-98 (2008).

222.   GUILLAMET E., A. CREUS, J. PONTI, E. SABBIONI, S. FORTANER, R. MARCOS. DNA-damage induction by eight metal compounds in TK6 human lymphoblastoid cells: Results obtained with the alkaline Comet assay. Mutation Research (GTEM), 654(1): 22-28 (2008).

223.   HERNÁNDEZ A., R. MARCOS. Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. Pharmacogenomics, 9(8): 1113-1132 (2008).

224. GUZMÁN A., C. GARCÍA, A.P. MARÍN, A. TORTAJADA, M.T. RUIZ, A.R. FERNÁNDEZ DE HENESTROSA, R. MARCOS. Formation of micronucleated erythrocytes in mouse bone marrow under conditions of hypothermia is not associated with stimulation of erythropoiesis. Mutation Research (GTEM), 656(1-2): 8-13 (2008).

225. SORIANO C., A. CREUS, R. MARCOS. Arsenic trioxide mutational spectrum analysis. Mutation Research (FMMM), 642(1-2): 1-7 (2008).

226.   RIO P., N.W. MEZA, A. GONZÁLEZ-MURILLO, S. NAVARRO, L. ALVAREZ, J. SURRALLÉS, M. CASTELLÀ, G. GUENECHEA, J.C. SEGOVIA, H. HANENBERG, J.A. BUEREN. In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1. Blood, 112: 4853-4861 (2008).

227. RAMÍREZ M.J., J. SURRALLÉS. Laser confocal microscopy analysis of human interphase nuclei by three-dimensional FISH reveals dynamic perinucleolar clustering of telomeres. Cytogenetics and Genome Research, 122: 237-242 (2008).

228. GUZMÁN A., A.P. MARÍN, C. GARCÍA, A.R. FERNÁNDEZ DE HENESTROSA, M.T. RUIZ, A. TORTAJADA, R. MARCOS. Induction of hypothermic conditions associated with increased micronuclei formation in sigma-1 receptor knockout mice after administration of the antipsychotic compound E-5842. Environmental and Molecular Mutagenesis, 49(9): 727-733 (2008).

229.   HERNÁNDEZ A., N. XAMENA, J. SURRALLÉS, P. GALOFRÉ, A. CREUS, A. VELÁZQUEZ, R. MARCOS. Role of GST and NAT2 polymorphisms in thyroid cancer. Journal of Endocrinological Investigation, 31(11): 1025-1031 (2008).

230. VAN ZEEBURG H., P. SNIJDERS, T. WU, E. GLUCKMAN, J. SOULIER, J. SURRALLÉS, M. CASTELLÀ, J. VAN DER WAL, J. WENNERBERG, J. C, EUNIKE VELLEUER, R. DIETRICH, W. EBELL, E. BLOEMENA, H. JOENJE, R. LEEMANS, R.H. BRAKENHOFF. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. Journal of the National Cancer Institute, 100: 1649-1653 (2008).



203. VILLANUEVA C.M., K.P. CANTOR, J.O. GRIMALT, N. MALATS, D. SILVERMAN, A. TARDON, R. GARCIA-CLOSAS, C. SERRA, A. CARRATO, G. CASTAÑO-VINYALS, R. MARCOS, N. ROTHMAN, F.X. REAL, M. DOSEMECI, M. KOGEVINAS. Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering and swimming pool attendance. The American Journal of Epidemiology, 165: 148-256 (2007).

204.   BOGLIOLO M., A. LYAKHOVICH, E. CALLÉN, M. CASTELLÀ, E. CAPPELLI, M.J. RAMÍREZ, A. CREUS, R. MARCOS, R. KALB, K. NEVELING, D. SCHINDLER, J. SURRALLÉS. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO Journal, 26: 1340-1351 (2007).

205.   CASADO J.A., E. CALLÉN, A. JACOME, P. RIO, M. CASTELLÀ, S. LOBITZ, T. FERRO, A. MUÑOZ, J. SEVILLA, A. CANTALEJO, E. CELA, J. CERVERA, J. SÁNCHEZ-CALERO, I. BADELL, J. ESTELLA, A. DASI, T. OLIVÉ, J.J. ORTEGA, A. RODRIGUEZ-VILLA, M. TAPIA, A. MOLINES, L. MADERO, J.C. SEGOVIA, K. NEVELING, R. KALB, D. SCHINDLER, H. HANENBERG, J. SURRALLÉS, J.A. BUEREN. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network. Journal of Medical Genetics, 44: 241-249 (2007).

206.   KALB R., K. NEVELING, H. HOEHN, K. GOETTSCHE, S.D. BATTISH, C. HUNT, M. BERWICK, E. CALLÉN, J. SURRALLÉS, J.A. CASADO, J. BUEREN, A. DASI,  C.M. ZWAAN, R. VERVENNE, G. PALS, J. DE WINTER, H. JOENJE, M. GROMPE, A.D. AUERBACH, H. HANENBERG, D. SCHINDLER. Hypomorphic mutations in the central Fanconi anemia gene /FANCD2/ sustain a significant group of FA-D2 patients with severe phenotype. American Journal of Human Genetics, 80: 895-910 (2007).

207.   CASTELLÀ M., S. PUERTO, A. CREUS, R. MARCOS, J. SURRALLÉS. Telomere length modulates human radiation sensitivity in vitro. Toxicology Letters, 172: 29-36 (2007).

208. SORIANO C., A. CREUS, R. MARCOS. Gene-mutation induction by arsenic compounds in the mouse lymphoma assay. Mutation Research (GTEM), 634: 40-50 (2007).

209.   LYAKHOVICH E., J. SURRALLÉS. FANCD2 depletion sensitises cancer cells repopulation ability in vitro. Cancer Letters, 256: 186-197 (2007).

210.   LYAKHOVICH E., J. SURRALLÉS. New roads to FA/BRCA pathway. Cell Cycle, 69: 1019-1023 (2007).

211.   LYAKHOVICH E., J. SURRALLÉS. How Fanconi anemia and breast cancer are connected. En: Frontiers in breast cancer research. L.P. Fortugno (Ed.) Nova Science Publisher, Inc. Cap. 10 (2007).

212.   LYAKHOVICH E., F. CANALS, M. NOSOV, J. SURRALLÉS. A DIGE-based approach to study interacting proteins. Journal of Biochemical and Biophysical Methods, 70: 693-695 (2007).



188.   MARCOS R., V. MARTÍNEZ, A. HERNÁNDEZ, A. CREUS, C. SEKARAN, H. TOKUNAGA, D. QUINTEROS. Metabolic profile in workers occupationally exposed to arsenic. Role of GST polymorphisms. Journal of Occupational and Environmental Medicine 48: 334-341 (2006).

189.   RIZKI M, E. KOSSATZ, A. VELÁZQUEZ, A. CREUS, M. FARINA, S. FORTANER, E. SABBIONI, R. MARCOS. Metabolism of arsenic in Drosophila melanogaster and the genotoxicity of dimethylarsinic acid in the Drosophila Wing Spot Test. Environmental and Molecular Mutagenesis 47: 162-168 (2006).

190.   BADAL M. A. PORTELA, E. BALDRICH, R. MARCOS, O. CABRÉ, N. XAMENA. An FB-NOF mediated duplication of the white gene is responsible for the zeste1 phenotype in some Drosophila melanogaster unstable strains. Molecular Genetics and Genomics, 275: 35-43 (2006).

191.   PAIVA L., V. MARTÍNEZ, A. CREUS, D. QUINTEROS, R. MARCOS. Sister chromatid exchanges analysis in smelting plant workers exposed to arsenic. Environmental and Molecular Mutagenesis, 47: 230-235 (2006).

192.   LYAKHOVICH A, J. SURRALLÉS. Disruption of the Fanconi anemia/BRCA pathway in spodadic tumors. Cancer Letters, 232: 99-106 (2006).

193.   FERRARA G., E. LOFFREDO, N. SENESI, R. MARCOS. Humic acids reduce the genotoxicity of mitomycin C in the human lymphoblastoid cell line TK6. Mutation Research (GTEM), 603: 27-32.194 (2006).

194.   BADAL M., A. PORTELA, N. XAMENA, O. CABRÉ. Molecular and bioinformatics analysis of the FB-NOF transposable element. Gene, 371: 130-135 (2006).

195.   HERNÁNDEZ A., N. XAMENA, S. GUTIÉRREZ, A. VELÁZQUEZ, A. CREUS, J. SURRALLÉS, P. GALOFRÉ, R. MARCOS. Basal and induced MN frequencies in different GST and NAT2 genetic backgrounds. Mutation Research (GTEM), 606: 12-20 (2006).

196. KIRSCH-VOLDERS M., R. MATEUCA, M. ROELANTS, A. TREMP, E. ZEIGER, S. BONASSI, N. HOLLAND, W.P. CHANG, P. AKA, M, DE BOECK, L.GODDERIS, V. HAUFROID, H. ISHIKAWA, B. LAFFON, R. MARCOS, L. MIGLIORE, H. NORPPA, J.P. TEIXEIRA, A. ZIJNO, M. FENECH. The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo. Cancer Epidemiology and Biomarkers Prevention, 15:1038-1042 (2006).

197.   PITARQUE M., A. CREUS, R. MARCOS. Analysis of glutathione and vitamin C effects on the benzenetriol-induced DNA damage in isolated human lymphocytes. TheScientificWorldJournal, 6: 1191-1201 (2006).

198.   CEMELI E., R. MARCOS, D. ANDERSON. Genotoxic and antigenotoxic properties of selenium compounds in the in vitro micronucleus assay with human whole blood lymphocytes and TK6 lymphoblastoid cells. TheScientificWorldJournal, 6: 1202-1210

199. PIPERAKIS S.M., K. KONTOGIANNI, M.M. PIPERAKIS, R. MARCOS, S. TSILIMIGAKI. Effects of pesticides on occupationally exposed humans. TheScientificWorldJournal 6: 1211-1220 (2006).

200.   NAVARRO S., N.W. MEZA, O. QUINTANA-BUSTAMANTE, J.A. CASADO, A. JACOME, K. MCALLISTER, S. PUERTO, J. SURRALLÉS, J.C. SEGOVIA, J.A. BUEREN. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Molecular Therapy 14: 525-535 (2006).

201.   GÜERCI A.M., L.A. ZÚÑIGA, R. MARCOS. Valor predictivo del ensayo cometa en la evaluación de  radiosensibilidad individual en sangre periférica. Theoria, 15: 41-52 (2006).

202. CHOWDHURY UK., RA.ZAKHARYAN, A. HERNÁNDEZ, MD. AVRAM, MJ. KOPPLIN, HV. APOSHIAN. Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicology and Applied Pharmacology, 216: 446-457 (2006).



Campus d'excel·lència internacional U A B